<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39451585</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Assessment of the Predictive Ability of the Neutrophil-to-Lymphocyte Ratio in Patients with In-Stent Restenosis after COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2262</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14202262</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The neutrophil-to-lymphocyte ratio (NLR) is an independent predictor of the severity of coronary heart disease and COVID-19. This study aims to assess the predictive ability of the NLR in patients with in-stent restenosis after COVID-19.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">a cross-sectional study included 931 patients who underwent repeated myocardial revascularization between May 2020 and May 2023. The 420 patients of the main group had in-stent restenosis, of which 162 patients had COVID-19 previously. The control group included 511 patients without stent restenosis (107 patients had COVID-19 previously). All reported events were verified by hospital electronic records from the Complex Medical Information System.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean values of the NLR were 2.51 and 2.68 in the study groups, respectively. A statistically significant positive relationship in both groups was found between the NLR and troponin, D-dimer, C-reactive protein, creatinine, ALT, and AST. A statistically significant positive relationship was found between NLR and myocardial infarction (MI) in patients of both groups (<i>p</i> = 0.004; <i>p</i> &lt; 0.001, respectively) and a negative relationship with the ejection fraction (<i>p</i> = 0.001; <i>p</i> &lt; 0.036, respectively). An evaluation of the predictive ability of the clinical and laboratory predictors of recurrent myocardial infarction shows a high degree of utility of this model. The area under the ROC curve for AUC for NLR was 0.664 with 95% CI from 0.627 to 0.700 (<i>p</i> &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NLR is one of the significant factors for predicting the development of adverse outcomes in patients with revascularized myocardium after COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pivina</LastName><ForeName>Lyudmila</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8035-4866</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Semey Medical University, Semey 071400, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batenova</LastName><ForeName>Gulnara</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Semey Medical University, Semey 071400, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ygiyeva</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Semey Medical University, Semey 071400, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orekhov</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7201-1399</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Semey Medical University, Semey 071400, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pivin</LastName><ForeName>Maksim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Semey Medical University, Semey 071400, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dyussupov</LastName><ForeName>Altay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rector Office, Semey Medical University, Semey 071400, Kazakhstan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AP19677465</GrantID><Agency>Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">in-stent thrombosis</Keyword><Keyword MajorTopicYN="N">neutrophil-to-lymphocyte ratio</Keyword><Keyword MajorTopicYN="N">restenosis</Keyword><Keyword MajorTopicYN="N">stenting</Keyword></KeywordList><CoiStatement>The authors declare they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39451585</ArticleId><ArticleId IdType="pmc">PMC11506230</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14202262</ArticleId><ArticleId IdType="pii">diagnostics14202262</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Torrado J., Buckley L., Durán A., Trujillo P., Toldo S., Valle Raleigh J., Abbate A., Biondi-Zoccai G., Guzmán L.A. Restenosis. Stent Thrombosis. and Bleeding Complications: Navigating Between Scylla and Charybdis. J. Am. Coll. Cardiol. 2018;71:1676–1695. doi: 10.1016/j.jacc.2018.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.02.023</ArticleId><ArticleId IdType="pubmed">29650125</ArticleId></ArticleIdList></Reference><Reference><Citation>MedMarket Diligence . Global Dynamics of Surgical and Interventional Cardiovascular Procedures. MedMarket Diligence; Foothill Ranch, CA, USA: 2016. 2015–2022 [Report #C500]</Citation></Reference><Reference><Citation>Gori T., Polimeni A., Indolfi C., Räber L., Adriaenssens T., Münzel T. Predictors of stent thrombosis and their implications for clinical practice. Nat. Rev. Cardiol. 2019;16:243–256. doi: 10.1038/s41569-018-0118-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0118-5</ArticleId><ArticleId IdType="pubmed">30518952</ArticleId></ArticleIdList></Reference><Reference><Citation>Windecker S., Kolh P., Alfonso F., Collet J.P., Cremer J., Falk V., Filippatos G., Hamm C., Head S.J., Jüni P., et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2014;35:2541–2619. doi: 10.5603/KP.2014.0224.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/KP.2014.0224</ArticleId><ArticleId IdType="pubmed">25173339</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Cardiovascular Diseases (CVDs)  [(accessed on 1 January 2020)].  Available online:  http://www.who.int/cardiovascular_diseases/en/</Citation></Reference><Reference><Citation>Alfonso F., Coughlan J.C., Giacoppo D., Kastrati A., Byrne R.B. Management of in-stent restenosis. EuroIntervention. 2022;18:e103–e123. doi: 10.4244/EIJ-D-21-01034.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-21-01034</ArticleId><ArticleId IdType="pmc">PMC9904384</ArticleId><ArticleId IdType="pubmed">35656726</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein L.W., Nathan S., Maehara A., Messenger J., Mintz G.S., Ali Z.A., Rymer J., Sandoval Y., Al-Azizi K., Mehran R., et al. SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis. J. Soc. Cardiovasc. Angiogr. Interv. 2023;2:100971. doi: 10.1016/j.jscai.2023.100971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2023.100971</ArticleId><ArticleId IdType="pmc">PMC11308135</ArticleId><ArticleId IdType="pubmed">39131655</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfonso F., Byrne R.A., Rivero F., Kastrati A. Current treatment of in-stent restenosis. J. Am. Coll. Cardiol. 2014;63:2659–2673. doi: 10.1016/j.jacc.2014.02.545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.02.545</ArticleId><ArticleId IdType="pubmed">24632282</ArticleId></ArticleIdList></Reference><Reference><Citation>Canfield J., Totary-Jain H. 40 Years of Percutaneous Coronary Intervention: History and Future Directions. J. Pers. Med. 2018;8:33. doi: 10.3390/jpm8040033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm8040033</ArticleId><ArticleId IdType="pmc">PMC6313463</ArticleId><ArticleId IdType="pubmed">30275411</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Yu H., Liu H., Pu D., Gao J., Jin X., Liu X., Yan A. Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents. J. Clin. Lab. Anal. 2020;34:e23108. doi: 10.1002/jcla.23108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23108</ArticleId><ArticleId IdType="pmc">PMC7083400</ArticleId><ArticleId IdType="pubmed">31729103</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfonso F., Gonzalo N., Rivero F., Escaned J. The year in cardiovascular medicine 2020: Interventional cardiology. Eur. Heart J. 2021;42:985–1003. doi: 10.1093/eurheartj/ehaa1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa1096</ArticleId><ArticleId IdType="pmc">PMC7928953</ArticleId><ArticleId IdType="pubmed">33448291</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenova Y., Pivina L., Khismetova Z., Auyezova A., Nurbakyt A., Kauysheva A., Ospanova D., Kuziyeva G., Kushkarova A., Ivankov A. Anticipating the Need for Healthcare Resources Following the Escalation of the COVID-19 Outbreak in the Republic of Kazakhstan. J. Prev. Med. Public Health. 2020;53:387–396. doi: 10.3961/jpmph.20.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.20.395</ArticleId><ArticleId IdType="pmc">PMC7733753</ArticleId><ArticleId IdType="pubmed">33296578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauguel-Moreau M., Prati G., Pillière R., Beaune S., Loeb T., Sawczynski B., Aïdan V., Hergault H., Ouadahi M., Szymanski C., et al. Impact of two COVID-19 national lockdowns on acute coronary syndrome admissions. Coron. Artery Dis. 2022;33:333–334. doi: 10.1097/MCA.0000000000001094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCA.0000000000001094</ArticleId><ArticleId IdType="pubmed">35503935</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryana K.K., Widiana R.I.G., Suharsono H., Pujasakti M.P., Putra W.W.S., Yaniswari N.M.D. Severity of anxiety disorder and other factors associated with disease severity among COVID-19 patients in a hospital, Bali, Indonesia. Med. J. Malays. 2021;76:461–465.</Citation><ArticleIdList><ArticleId IdType="pubmed">34305105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubrano V., Zym L., Balzan S. Neutrophyl to lymphocyte ratio and c reactive protein are indipendent predictors of severe coronary artery disease: Comparison with hydroperoxides and consolidated inflammatory markers. Theor. Biol. Forum. 2018;111:49–56.</Citation><ArticleIdList><ArticleId IdType="pubmed">31089668</ArticleId></ArticleIdList></Reference><Reference><Citation>Küçükseymen S., Çağırcı G., Güven R., Arslan Ş. Is neutrophyl to lymphocyte ratio really a useful marker for all grades of degenerative aortic stenosis? Türk Kardiyol. Derneği Arşivi. 2017;45:506–513. doi: 10.5543/tkda.2017.32389.</Citation><ArticleIdList><ArticleId IdType="doi">10.5543/tkda.2017.32389</ArticleId><ArticleId IdType="pubmed">28902640</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedrizal F.F., Wijaya I.P., Abdullah M., Yamin M. Elevated neutrophil-to-lymphocyte ratio and smoking are associated with chronic total occlusion in patients with ST elevation myocardial infarction. BMC Cardiovasc. Disord. 2024;24:12. doi: 10.1186/s12872-023-03680-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-023-03680-3</ArticleId><ArticleId IdType="pmc">PMC10765767</ArticleId><ArticleId IdType="pubmed">38172732</ArticleId></ArticleIdList></Reference><Reference><Citation>Haybar H., Pezeshki S.M.S., Saki N. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis? Exp. Mol. Pathol. 2019;110:104267. doi: 10.1016/j.yexmp.2019.104267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2019.104267</ArticleId><ArticleId IdType="pubmed">31194963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponti G., Maccaferri M., Ruini C., Tomasi A., Ozben T. Biomarkers associated with COVID-19 disease progression. Crit. Rev. Clin. Lab. Sci. 2020;57:389–399. doi: 10.1080/10408363.2020.1770685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1770685</ArticleId><ArticleId IdType="pmc">PMC7284147</ArticleId><ArticleId IdType="pubmed">32503382</ArticleId></ArticleIdList></Reference><Reference><Citation>Long L., Zeng X., Zhang X., Xiao W., Guo E., Zhan W., Yang X., Li C., Wu C., Xu T., et al. Short-term outcomes of coronavirus disease 2019 and risk factors for progression. Eur. Respir. J. 2020;55:2000990. doi: 10.1183/13993003.00990-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00990-2020</ArticleId><ArticleId IdType="pmc">PMC7173674</ArticleId><ArticleId IdType="pubmed">32312863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagunas-Rangel F.A. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J. Med. Virol. 2020;92:1733. doi: 10.1002/jmv.25819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25819</ArticleId><ArticleId IdType="pmc">PMC7228336</ArticleId><ArticleId IdType="pubmed">32242950</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolicoeur P., Lamontagne L. Impairment of bone marrow pre-B and B cells in MHV3 chronically-infected mice. Adv. Exp. Med. Biol. 1995;380:193–195.</Citation><ArticleIdList><ArticleId IdType="pubmed">8830480</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Q., Li P., Ye X., Huang X., Mo X., Wang Q., Zhang Y., Luo K., Chen Z., Luo J., et al. Longitudinal peripheral blood transcriptional analysis of COVID-19 patients captures disease progression and reveals potential biomarkers. J. Immunol. 2021;206:2146–2159. doi: 10.4049/jimmunol.2001325.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2001325</ArticleId><ArticleId IdType="pubmed">33846224</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z., Fu Z., Huang W., Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. Am. J. Emerg. Med. 2020;38:641–647. doi: 10.1016/j.ajem.2019.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2019.10.023</ArticleId><ArticleId IdType="pubmed">31785981</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M., Graubard B.I., Rabkin C.S., Engels E.A. Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Sci. Rep. 2021;11:464. doi: 10.1038/s41598-020-79431-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79431-7</ArticleId><ArticleId IdType="pmc">PMC7801737</ArticleId><ArticleId IdType="pubmed">33431958</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortaz E., Alipoor S.D., Adcock I.M., Mumby S., Koenderman L. Update on Neutrophil Function in Severe Inflammation. Front. Immunol. 2018;9:2171. doi: 10.3389/fimmu.2018.02171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02171</ArticleId><ArticleId IdType="pmc">PMC6190891</ArticleId><ArticleId IdType="pubmed">30356867</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Guo J., Bi L. Role of the NLRP3 inflammasome in autoimmune diseases. Biomed. Pharmacother. 2020;130:110542. doi: 10.1016/j.biopha.2020.110542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110542</ArticleId><ArticleId IdType="pubmed">32738636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowsby R., Gomes C., Jarman I., Lisboa P., Nee P.A., Vardhan M., Eckersley T., Saleh R., Mills H. Neutrophil to lymphocyte count ratio as an early indicator of blood stream infection in the emergency department. Emerg. Med. J. 2015;32:531–534. doi: 10.1136/emermed-2014-204071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2014-204071</ArticleId><ArticleId IdType="pubmed">25183249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Liu R., Yu X., Yang R., Xu H., Mao Z., Wang Y. The neutrophil-lymphocyte count ratio as a diagnostic marker for bacteraemia: A systematic review and meta-analysis. Am. J. Emerg. Med. 2019;37:1482–1489. doi: 10.1016/j.ajem.2018.10.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2018.10.057</ArticleId><ArticleId IdType="pubmed">30413366</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu D., Huang Q., Yang F., Tian W., Li C., Ding L.A., Fang H.C., Zhao Y. Serum biomarkers to differentiate Gram-negative. Gram-positive and fungal infection in febrile patients. J. Med. Microbiol. 2021;70:001360. doi: 10.1099/jmm.0.001360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001360</ArticleId><ArticleId IdType="pubmed">34259621</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi D., Sharma A., Shrestha S.K., Sharma R., Bhatta Y.K.D., Rajbanshi B.G. Coronary Artery Bypass Grafting Following COVID-19 Infection: Difficulties and Challenges. J. Nepal. Health Res. Counc. 2022;20:555–557.</Citation><ArticleIdList><ArticleId IdType="pubmed">36550744</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Hou M., Ding Z., Liu X., Shao Y., Li X. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Stroke: A Systematic Review and Meta-Analysis. Front. Neurol. 2021;12:686–983. doi: 10.3389/fneur.2021.686983.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.686983</ArticleId><ArticleId IdType="pmc">PMC8497704</ArticleId><ArticleId IdType="pubmed">34630275</ArticleId></ArticleIdList></Reference><Reference><Citation>Forget P., Khalifa C., Defour J.-P., Latinne D., Van Pel M.-C., De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res. Notes. 2017;10:12. doi: 10.1186/s13104-016-2335-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-016-2335-5</ArticleId><ArticleId IdType="pmc">PMC5217256</ArticleId><ArticleId IdType="pubmed">28057051</ArticleId></ArticleIdList></Reference><Reference><Citation>Fest J., Ruiter T.R., Koerkamp B.G., Rizopoulos D., Ikram M.A., Van Eijck C.H.J., Stricker B.H. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study. Eur. J. Epidemiol. 2019;34:463–470. doi: 10.1007/s10654-018-0472-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-018-0472-y</ArticleId><ArticleId IdType="pmc">PMC6456469</ArticleId><ArticleId IdType="pubmed">30569368</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakonstantis S., Kalemaki D., Tzagkarakis E., Lydakis C. Pitfalls in studies of eosinopenia and neutrophil-to-lymphocyte count ratio. Infect. Dis. 2018;50:163–174. doi: 10.1080/23744235.2017.1388537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2017.1388537</ArticleId><ArticleId IdType="pubmed">29070003</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga C.G., Gonçalves P.A., Cardoso P., Fiarresga A., Santos L., Domingues A., Costa M., Ferreira R., Duarte J., Seixo F., et al. Impact of the COVID-19 pandemic on percutaneous coronary interventions in Portugal. Rev. Port. Cardiol. 2023;42:1–6. doi: 10.1016/j.repc.2021.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.repc.2021.03.021</ArticleId><ArticleId IdType="pmc">PMC9411142</ArticleId><ArticleId IdType="pubmed">36043164</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Li Q., Liang W., Yan R., Tong L., Jia M., Zhao C., Zhao W. TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation. Nat. Commun. 2021;12:4794. doi: 10.1038/s41467-021-25033-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25033-4</ArticleId><ArticleId IdType="pmc">PMC8352945</ArticleId><ArticleId IdType="pubmed">34373456</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesia Patient Safety Foundation  American Society of Anesthesiologists and Anesthesia Patient Safety Foundation Joint Statement on Elective Surgery and Anesthesia for Patients after COVID-19 Infection.  [(accessed on 30 March 2022)].  Available online:  https://www.apsf.org/newsupdates/asa-and-apsf-joint-statement-on-elective-surgery-and-anesthesia-for-patients-after-covid-19-infection/</Citation></Reference><Reference><Citation>Antonioli L., Pacher P., Vizi E.S., Haskó G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 2013;19:355–367. doi: 10.1016/j.molmed.2013.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2013.03.005</ArticleId><ArticleId IdType="pmc">PMC3674206</ArticleId><ArticleId IdType="pubmed">23601906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambataro G., Sambataro D., Torrisi S.E., Vancheri A., Pavone M., Rosso R., Schisano M., Crimi C., Pignataro F., Fischer A., et al. State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances. Eur. Respir. Rev. 2018;27:170139. doi: 10.1183/16000617.0139-2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0139-2017</ArticleId><ArticleId IdType="pmc">PMC9488748</ArticleId><ArticleId IdType="pubmed">29720509</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah N., Parikh V., Patel N., Patel N., Badheka A., Deshmukh A., Rathod A., Lafferty J. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III. Int. J. Cardiol. 2014;171:390–397. doi: 10.1016/j.ijcard.2013.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.12.019</ArticleId><ArticleId IdType="pubmed">24388541</ArticleId></ArticleIdList></Reference><Reference><Citation>Azab B., Zaher M., Weiserbs K.F., Torbey E., Lacossiere K., Gaddam S., Gobunsuy R., Jadonath S., Baldari D., McCord D., et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am. J. Cardiol. 2010;106:470–476. doi: 10.1016/j.amjcard.2010.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2010.03.062</ArticleId><ArticleId IdType="pubmed">20691303</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamhane U.U., Aneja S., Montgomery D., Rogers E.-K., Eagle K.A., Gurm H.S. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am. J. Cardiol. 2008;102:653–657. doi: 10.1016/j.amjcard.2008.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.05.006</ArticleId><ArticleId IdType="pubmed">18773982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Fan J., Billiar T.R., Scott M.J. Inflammasome and autophagy regulation—A two-way street. Mol. Med. 2017;23:188–195. doi: 10.2119/molmed.2017.00077.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2017.00077</ArticleId><ArticleId IdType="pmc">PMC5588408</ArticleId><ArticleId IdType="pubmed">28741645</ArticleId></ArticleIdList></Reference><Reference><Citation>Golia E., Limongelli G., Natale F., Fimiani F., Maddaloni V., Pariggiano I., Bianchi R., Crisci M., D’acierno L., Giordano R., et al. Inflammation and cardiovascular disease: From pathogenesis to therapeutic target. Curr. Atheroscler. Rep. 2014;16:435. doi: 10.1007/s11883-014-0435-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-014-0435-z</ArticleId><ArticleId IdType="pubmed">25037581</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyit M., Avci E., Nar R., Senol H., Yilmaz A., Ozen M., Oskay A., Aybek H. Neutrophil to lymphocyte ratio. lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am. J. Emerg. Med. 2021;40:110–114. doi: 10.1016/j.ajem.2020.11.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.11.058</ArticleId><ArticleId IdType="pmc">PMC7719281</ArticleId><ArticleId IdType="pubmed">33309506</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang Y.-M., Tang Y., Chen J.-Q., Shao Z.-Q. The evolution of plant NLR immune receptors and downstream signal components. Curr. Opin. Plant Biol. 2023;73:102363. doi: 10.1016/j.pbi.2023.102363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbi.2023.102363</ArticleId><ArticleId IdType="pubmed">37094492</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>